HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA® safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets,

First Page		Document Content
Date: 2015-03-10 17:24:06 Pharmacology Antibiotics Eli Lilly and Company Biguanides Guanidines Metformin Renal function Nitrofurantoin Anti-diabetic medication Medicine Thiazolidinediones Chemistry		HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use INVOKANA® safely and effectively. See full prescribing information for INVOKANA. INVOKANA (canagliflozin) tablets, Add to Reading List Source URL: www.invokana.com Download Document from Source Website File Size: 761,83 KB Share Document on Facebook

	Recall: Riomet™ (Metformin Hydrochloride Oral Solution): Microbial Contamination At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform that on November 27, 2017 the DocID: 1vpXt - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tj6K - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tcHG - View Document
	FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function DocID: 1t6MV - View Document
	Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog DocID: 1qXHV - View Document